Analyst Ratings for Horizon Therapeutics (HZNP)
HZNP Rating Summary
HZNP Price Target Summary
- Highest: $144.00 (Goldman Sachs)
- Lowest: $74.00 (H.C. Wainwright)
- Average: $109.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$109.00 (-0.5%)
* Over Last 12-Mos
Rating Score: 5.2 / 10
Percentile Rank: 55%
Avg. $ Target:
$109.00 (-0.5%)
* Over Last 12-Mos
Rating Score: 5.2 / 10
Percentile Rank: 55%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/13/2022 | SVB Leerink | Joseph P. Schwartz | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
112.36 (109.60) |
-2.46% | Details |
| 12/13/2022 | Guggenheim | Yatin Suneja | Downgrade | Neutral (Buy) |
116.50 (98.00) |
112.36 (109.60) |
-2.46% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
